By Nana O 
A groundbreaking preclinical study from Weill Cornell Medicine researchers suggests that the intricate three-dimensional folding of DNA within the nucleus of brain cells may offer a crucial pathway to understanding and potentially treating glioblastoma, one of the most aggressive and currently incurable forms of brain cancer. Published on April 3 in the esteemed journal Molecular Cell, these findings herald a significant shift in how scientists conceptualize cancer, moving beyond a sole focus on gene mutations to encompass the spatial organization and regulatory logic of genes within the cell’s nucleus.
This novel perspective challenges conventional approaches to glioblastoma research, which have historically concentrated on identifying specific genetic mutations driving the disease. Despite extensive knowledge of these mutations and the genes involved, effective therapeutic strategies to halt glioblastoma’s relentless progression remain elusive.
A Fresh Perspective on an Intractable Cancer
"Glioblastoma is one of the most aggressive and incurable tumors," stated Dr. Effie Apostolou, associate professor of molecular biology in medicine at Weill Cornell and co-leader of the study. "Although we know a lot about the mutations and the genes that characterize it, we still have no effective ways to stop it. Now, we’re bringing a fresh perspective to the problem. We may have a chance of figuring out the regulatory logic of this cancer and identifying potential control centers that we can target to eliminate it."
The fundamental challenge addressed by the Weill Cornell team lies in the astonishing compactness of our genetic material. The human genome, when stretched out linearly, measures approximately six feet in length. To fit this immense length into the microscopic nucleus of a cell, which is roughly 80 times smaller than a grain of sand, DNA undergoes extensive and highly organized folding. This complex three-dimensional architecture brings distant regions of the linear DNA molecule into close proximity, facilitating interactions and regulatory processes that are not apparent when examining DNA in a simple linear fashion.
"By examining the DNA organization in the 3D space, we uncovered hubs where multiple genetic regions that look like they should be disconnected are actually able to communicate and work together," Dr. Apostolou explained. In healthy cells, these "gene hubs" are thought to orchestrate essential physiological processes, such as embryonic development and cellular differentiation. However, the researchers’ analysis of glioblastoma cells revealed a starkly different scenario.
Unraveling Cancerous Gene Hubs in Glioblastoma
When analyzing glioblastoma cells obtained from various patients, the Weill Cornell Medicine team observed that cancer-promoting genes were abnormally clustered together within these three-dimensional hubs. Crucially, these oncogenic genes were found to be in direct communication not only with other known glioblastoma-related genes but also with genes previously not implicated in the cancer’s development. This suggests that the spatial arrangement of DNA is actively contributing to, or even driving, the aberrant behavior of cancer cells.
Dr. Howard Fine, the Louis and Gertrude Feil Professor of Medicine in Neurology at Weill Cornell Medicine and director of the Brain Tumor Center at NewYork-Presbyterian/Weill Cornell Medical Center, who co-led the study, emphasized the significance of these findings. "This study shows that the 3D organization of DNA inside tumor cells plays a powerful role in driving brain cancer behavior — sometimes even more than mutations themselves," Dr. Fine remarked. This assertion underscores the study’s core message: the physical arrangement of genetic material within the nucleus is not merely a passive consequence of cellular structure but an active participant in disease pathogenesis.
The study’s co-first authors, Dr. Sarah Breves, a surgical resident at NewYork-Presbyterian/Weill Cornell Medical Center working in Dr. Apostolou’s lab, and Dr. Dafne Campigli Di Giammartino from the Instituto Italiano di Tecnologia in Genoa, Italy, played pivotal roles in this research.
3D Gene Hubs: Form Dictating Function
In healthy individuals, the DNA regions that form these critical hubs in glioblastoma cells are typically transcriptionally quiescent, meaning the genes within these regions are largely inactive and not producing proteins that influence cellular function. The researchers hypothesized that disrupting these specific hubs could alter the oncogenic program of glioblastoma cells.
To test this hypothesis, the team utilized tumor samples from patients undergoing treatment at NewYork-Presbyterian/Weill Cornell Medical Center, with their informed consent. They employed a sophisticated gene-editing tool known as CRISPR interference (CRISPRi) to selectively silence a suspected cancer-related hub within glioblastoma cells cultured in laboratory dishes.
The results were striking. Silencing this specific hub triggered a cascading effect, akin to a domino effect, within the cancer cells. The activity of numerous genes connected to the silenced hub significantly decreased. Multiple genes known to drive cancer progression were disrupted, and importantly, the glioblastoma cells exhibited a reduced ability to form tumor-like spheres. This experimental manipulation demonstrated a direct link between the spatial organization of DNA and the aggressive, proliferative nature of glioblastoma.
"We were able to alter the oncogenic program of glioblastoma cells and their ability to organize and form something like cancer in the dish," Dr. Apostolou elaborated, highlighting the potential of targeting these spatial regulatory mechanisms.
Beyond Brain Cancer: A Universal Phenomenon?
The implications of these findings extend far beyond glioblastoma. Motivated by their discoveries in brain cancer, the researchers broadened their investigation to examine previously published analyses of 16 different cancer types. Their comprehensive review revealed a compelling pattern: hyperconnected three-dimensional gene hubs appear to be a common feature across a wide spectrum of cancers, including melanoma, lung cancer, prostate cancer, and uterine cancer, among others.
While each specific cancer type exhibits a unique constellation of interconnected gene hubs, the study also identified shared hubs that are prevalent across multiple cancer types. This suggests that the underlying principle of disrupted 3D DNA organization as a driver of cancer may be a more universal biological phenomenon than previously understood.
An especially significant observation from the team was that the formation of these aberrant 3D hubs is not typically driven by overt genetic mutations, such as DNA breaks, amplifications, or rearrangements. Instead, these structural alterations often arise from epigenetic changes. Epigenetics refers to modifications that affect gene expression without altering the underlying DNA sequence. These changes can influence how DNA is packaged around proteins called histones and how cellular machinery controls whether genes are switched on or off. The protein complexes that bind to specific DNA sequences and regulate gene activity are intimately involved in the formation and maintenance of these critical 3D hubs.
Targeting the Spatial Genome: A New Frontier in Cancer Therapy
The identification of these key control hubs within the 3D genome structure opens up exciting new avenues for therapeutic intervention. "By identifying key control hubs in this 3D structure, we’ve uncovered new potential targets for future treatments," said Dr. Fine, who also serves as the associate director for translational research at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.
The next crucial steps for the research team involve delving deeper into the mechanisms by which these hubs form and investigating whether these structures can be safely and effectively disrupted to impede or halt tumor growth. The study’s findings strongly suggest that targeting the epigenetic landscape and the spatial organization of the genome could serve as a powerful complementary strategy to existing traditional molecular therapies.
The potential implications for future cancer treatment are profound. If these 3D gene hubs are indeed central drivers of cancer progression across multiple tumor types, developing therapies that specifically target and dismantle these structures could offer a novel approach to treating cancers that are currently resistant to conventional therapies. This research represents a significant step forward in understanding the complex, multi-layered nature of cancer and offers renewed hope for patients battling devastating diseases like glioblastoma. The shift in focus from purely genetic mutations to the intricate spatial regulation of the genome marks a paradigm shift in cancer research, potentially unlocking previously inaccessible therapeutic targets.
